ARTA
SVA

A.R.T. Advisors’s Sinovac Biotech, Ltd SVA Stock Holding History

A.R.T. Advisors’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-15,562
Closed -$81K – 1968
2014
Q4 		$81K Sell
15,562
-25,570
-62% -$130K ﹤0.01% 1320
2014
Q3 		$197K Sell
41,132
-16,600
-29% -$89.1K 0.01% 1107
2014
Q2 		$325K Sell
57,732
-37,100
-39% -$225K 0.02% 958
2014
Q1 		$682K Buy
94,832
+57,860
+156% +$383K 0.04% 640
2013
Q4 		$226K Buy
+36,972
New +$223K 0.01% 1072
2013
Q3 		– Sell
-43,175
Closed -$169K – 1759
2013
Q2 		$169K Buy
+43,175
New +$161K 0.01% 1187

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

A.R.T. Advisors's SVA Position: Q1 2015 in Review

A.R.T. Advisors sold out of Sinovac Biotech, Ltd (SVA) in Q1 2015, closing a stake of 15,562 shares — an estimated $81K sold.

A.R.T. Advisors first reported a position in SVA in Q2 2013 and held it in 6 quarters. The position peaked at $682K in Q1 2014. 40 funds tracked by Wall St. Rank hold SVA as of Q1 2015.

  • A.R.T. Advisors reported no remaining Sinovac Biotech, Ltd position as of Q1 2015 after selling out during the quarter.
  • A.R.T. Advisors sold 15,562 Sinovac Biotech, Ltd shares in Q1 2015, an estimated $81K.
  • A.R.T. Advisors first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 6 quarters.
  • A.R.T. Advisors's Sinovac Biotech, Ltd position peaked at $682K in Q1 2014.
  • 40 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2015.

Based on A.R.T. Advisors's 13F filing for Q1 2015, filed 15 May 2015.